Optimal Management of Pain in Hospitalized Patients - Opioid Tolerant Populations.
Status: | Recruiting |
---|---|
Conditions: | Chronic Pain, Chronic Pain, Post-Surgical Pain |
Therapuetic Areas: | Musculoskeletal |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 6/27/2018 |
Start Date: | January 2016 |
End Date: | November 2025 |
Contact: | Padma Gulur, MD |
Email: | padma.gulur@duke.edu |
Phone: | (919) 681-4660 |
Pain Management Options for Opioid Tolerant Patients: a Randomized Controlled Trial
Pain is a symptom that drives hospital admissions, and pain management is required by most
patients during their hospital stay. Further, the use of medications such as opioids can lead
to upward-spiraling doses, especially among chronic pain patients whose resource utilization
rates are high. Many initiatives aim to reduce the costs of these "high-resource utilizing"
patients. One exciting aspect of improving the management of pain is that this may help
prevent patients from ever becoming high-cost in the first place. The purpose of this study
is to examine the impacts of an early and sustained intervention pathway, in comparison to
the current standard of care, for the treatment of pain in opioid tolerant patients. It is
hypothesized that patients randomized to the intervention pathway, in comparison to the
control, will lead to decreased costs of care, a reduction in opioid usage within 3 and 6
months, and decrease in hospital readmission rates.
patients during their hospital stay. Further, the use of medications such as opioids can lead
to upward-spiraling doses, especially among chronic pain patients whose resource utilization
rates are high. Many initiatives aim to reduce the costs of these "high-resource utilizing"
patients. One exciting aspect of improving the management of pain is that this may help
prevent patients from ever becoming high-cost in the first place. The purpose of this study
is to examine the impacts of an early and sustained intervention pathway, in comparison to
the current standard of care, for the treatment of pain in opioid tolerant patients. It is
hypothesized that patients randomized to the intervention pathway, in comparison to the
control, will lead to decreased costs of care, a reduction in opioid usage within 3 and 6
months, and decrease in hospital readmission rates.
Inclusion Criteria:
- Adult patients (18 years and older)
- Known opioid tolerant (as determined per FDA criteria)
- Agree to sign the informed consent and HIPAA forms
Exclusion Criteria:
- Patients under the age of 18 years
- No known opioid tolerance
- Do not agree to sign the informed consent and HIPAA forms
We found this trial at
2
sites
101 The City Drive South
Orange, California 92868
Orange, California 92868
714-456-7890
Principal Investigator: Padma Gulur, MD
Phone: 617-633-9191
University of California, Irvine Medical Center We are UC Irvine Health. We are a devoted...
Click here to add this to my saved trials
2301 Erwin Rd
Durham, North Carolina 27710
Durham, North Carolina 27710
919-684-8111
Principal Investigator: Padma Gulur, MD
Phone: 919-681-4660
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
Click here to add this to my saved trials